Tablet Helps Heart Failure Patients Manage their Disease Including Drug Dosages

A novel tablet is helping heart failure patients to manage their disease including drug dosages, according to research presented at EuroHeartCare 2017.(1) Heart failure is a serious condition in which the heart does not pump blood around the body as well as it should. Not enough blood gets to the body, causing fatigue. Blood backs up waiting to enter the heart, leading to fluid accumulation in the legs and abdomen and fluid in the lungs (congestion).

Patients with heart failure are prescribed diuretics which act on the kidneys to produce more urine, thereby reducing fluid retention and congestion. Patients are advised to monitor their weight, as a rapid loss could be a sign that the diuretic dose is too high while a sudden gain could indicate fluid retention and require reducing the dose.

"Approximately 60% of patients with heart failure receive treatment and follow up in primary care," said lead author Maria Liljeroos, a nurse and deputy head of the coronary care unit, Mälarsjukhuset Hospital, Eskilstuna, Sweden, and a PhD student at Linköping University, Sweden. "Providing education to increase self-care is often a challenge in primary care due to lack of experience about heart failure and time."

To improve the delivery of evidence based care for heart failure patients in all parts of the healthcare system, in 2010 a county council in Sweden established heart failure clinics in primary care. It also decided to test whether an e-health tool, called OPTILOGG, could help patients self-manage their condition.

OPTILOGG is a pre-programmed tablet attached to a weighing scale that provides heart failure education, registers body weight and symptoms, and titrates diuretics. If the tool detects heart failure deterioration, the patient is instructed to increase the dose of diuretics. If weight gain is above a pre-determined range patients should contact the heart failure clinic. Patients can use OPTILOGG as required without pushing any buttons and it takes less than 30 seconds a day.

OPTILOGG was previously shown to improve self-care in patients followed up by specialised heart failure clinics after hospitalisation. The current study evaluated its effectiveness in primary care. The study had three aims: to assess patients' adherence to using OPTILOGG, to explore nurses' experiences of the implementation, and to evaluate the effects on self-care behaviours.

Patients' adherence to using OPTILOGG was registered automatically and data was retrieved after four months. The introduction of the tool was assessed by semi-structured interviews with eight heart failure nurses at four months. Data on self-care behaviour was collected using the validated nine item European Heart Failure Self-Care Behaviour Scale (EHFScB-9) at baseline and after four months. Responses to each item ranged from 0-5 with lower scores indicating better self-care behaviour.

The study included 32 patients from four primary care heart failure clinics. Participants were 65 years old on average and 31% were female. The researchers found that 94% of patients used OPTILOGG as intended. Nurses reported that the introduction of the tool did not increase their workload. The median total score on the self-care behaviour scale significantly decreased from 28.5 at baseline to 18 at four months.

Ms Liljeroos said: "Patients' self-care behaviours improved by 10.5 points or 37% when they used OPTILOGG. The nurses said patients felt safer and were more committed to taking better care of themselves when using the tool. We also found that it did not create more work for nurses."

She concluded: "Our study shows that introducing OPTILOGG into primary care is feasible and has the potential to help patients with heart failure to manage their condition. Following the results of our study, the tool is now available at all specialised and primary care heart failure clinics in the county council."

1. Ms Liljeroos has presented the abstract 'Implementation of an e-Health tool in heart failure clinics in primary care' during the Oral abstract session - Doctoral Students.

About EuroHeartCare
EuroHeartCare is the annual congress of the Council on Cardiovascular Nursing and Allied Professions (CCNAP) of the European Society of Cardiology (ESC). The 2017 congress will be held in collaboration with the Swedish Association on Cardiovascular Nursing and Allied Professions (VIC).

About the Council on Cardiovascular Nursing and Allied Professions
The Council on Cardiovascular Nursing and Allied Professions (CCNAP) aims to promote excellence in Cardiovascular Nursing and Allied Professions through practice education and research. In addition to nurses, allied health professionals belonging to the CCNAP include physiotherapists, dieticians, psychologists, cath lab technicians, imaging and diagnostic technicians and therapists working in rehabilitation and prevention. The CCNAP is one of five Councils of the European Society of Cardiology.

About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 120 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...